Jiangsu GDK Biotechnology Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.038x

Jiangsu GDK Biotechnology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jiangsu GDK Biotechnology Co Ltd (688670) has a cash flow conversion efficiency ratio of -0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-44.96 Million ≈ $-6.58 Million USD) by net assets (CN¥1.19 Billion ≈ $174.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jiangsu GDK Biotechnology Co Ltd (2017–2025)

Cash flow conversion efficiency of Jiangsu GDK Biotechnology Co Ltd from 2017 to 2025. This chart illustrates how Jiangsu GDK Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688670 stock price for real-time trading data and today's change.

Jiangsu GDK Biotechnology Co Ltd Cash Flow Conversion Ratio Explained

Jiangsu GDK Biotechnology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jiangsu GDK Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu GDK Biotechnology Co Ltd ranked by their cash flow conversion efficiency. Also see Jiangsu GDK Biotechnology Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Batavia Prosperindo Int JK:BPII	0.016x
Launchpad Cadenza Acquisition Corp I Class A Ordinary Share NASDAQ:LPCV	-0.001x
Cantabil Retail India Limited NSE:CANTABIL	0.074x
Kaltura Inc NASDAQ:KLTR	-1.154x
Nautilus Biotechnology Inc NASDAQ:NAUT	-0.105x
Sakar Healthcare Limited NSE:SAKAR	0.094x
Chongqing Wanli New Energy Co Ltd SHG:600847	-0.029x
TYC Brother Industrial Co Ltd TW:1522	0.061x

Annual Cash Flow Conversion Efficiency for Jiangsu GDK Biotechnology Co Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu GDK Biotechnology Co Ltd from 2017 to 2025. Review Jiangsu GDK Biotechnology Co Ltd (688670) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.10 Billion ≈ $160.83 Million	CN¥-166.45 Million ≈ $-24.36 Million	-0.151x	-47.26%
2024-12-31	CN¥1.28 Billion ≈ $186.95 Million	CN¥-131.39 Million ≈ $-19.23 Million	-0.103x	-274.28%
2023-12-31	CN¥1.37 Billion ≈ $200.63 Million	CN¥80.90 Million ≈ $11.84 Million	0.059x	+123.17%
2022-12-31	CN¥1.46 Billion ≈ $213.60 Million	CN¥38.60 Million ≈ $5.65 Million	0.026x	-62.82%
2021-12-31	CN¥1.46 Billion ≈ $213.84 Million	CN¥103.93 Million ≈ $15.21 Million	0.071x	-84.24%
2020-12-31	CN¥242.50 Million ≈ $35.49 Million	CN¥109.46 Million ≈ $16.02 Million	0.451x	-9.49%
2019-12-31	CN¥-108.38 Million ≈ $-15.86 Million	CN¥-54.05 Million ≈ $-7.91 Million	0.499x	+25.58%
2018-12-31	CN¥-89.34 Million ≈ $-13.07 Million	CN¥-35.48 Million ≈ $-5.19 Million	0.397x	-26.73%
2017-12-31	CN¥-61.33 Million ≈ $-8.97 Million	CN¥-33.24 Million ≈ $-4.86 Million	0.542x	--

About Jiangsu GDK Biotechnology Co Ltd

SHG:688670 China Biotechnology

Market Cap

$231.66 Million

CN¥1.58 Billion CNY

Market Cap Rank

#15718 Global

#4576 in China

Share Price

CN¥12.85

Change (1 day)

-2.06%

52-Week Range

CN¥11.85 - CN¥30.90

All Time High

CN¥75.07